Current Ependymoma Clinical Trials
The CERN Foundation launched three separate ependymoma clinical trials so far, two for adult patients and one for pediatric patients.
Clinical trials are an important part of the CERN Foundation’s many projects and collaboration. Our hope in these trials, and in all of our work, is to collect critical data that will advance a cure.
There are two pediatric clinical trials for ependymoma, both now closed to accrual. The CERN Foundation is in the process of launching our next pediatric clinical trial. Participating sites will begin accruing patients across the CERN network in the coming months.
There are two adult clinical trials for ependymoma, sponsored by the CERN Foundation, one trial is open and one is closed to accrual.
Basics About Clinical Trials
To make the best treatment decisions, patients need to understand all of their treatment options – including the availability of clinical trials to treat their disease.